What it is
Bronchogen is a man-made tetrapeptide whose chain reads Ala-Glu-Asp-Leu — alanine, glutamic acid, aspartic acid, leucine. It belongs to the St Petersburg series of short "bioregulator" peptides associated with V. Khavinson, each named for an organ — this one for the bronchi. A 2023 docking study from the same programme lists it, as AEDL, among 26 "biologically active ultrashort peptides" (PMID 36979488).
| Property | Value | Source |
|---|---|---|
| Sequence | Ala-Glu-Asp-Leu (AEDL) | PubChem; PMID 22808515 |
| Length | 4 amino acids | — |
| Formula | C18H30N4O9 | PubChem CID 11690869 |
| Molecular weight | 446.5 | PubChem |
A sequence the papers disagree on. The title of a 2011 paper reads "Effect of the peptide bronchogen (Ala-Asp-Glu-Leu) on DNA thermostability" (Monaselidze et al., PMID 21240358). PubChem's structure for "bronchogen" and a 2012 paper with Khavinson as first author give Ala-Glu-Asp-Leu. Swapping two residues makes a different molecule; this entry follows PubChem and the 2012 paper, and the 2011 order is labelled here as a discrepancy rather than resolved.
The family resemblance. The heart-labelled Cardiogen is Ala-Glu-Asp-Arg and the brain-labelled Cortagen is Ala-Glu-Asp-Pro: the three differ only in the last amino acid.
What PubMed holds
Searched by name on 2026-11-19, PubMed returns just seven papers, spanning 2006–2017, and Khavinson co-signs four of them.
| Year | What was studied | People given the peptide? |
|---|---|---|
| 2006 | Organ-type tissue cultures from young and old rats (PMID 17152728, title) | No |
| 2011 | DNA melting in calorimetry (PMID 21240358) | No |
| 2011 | Fluorescent peptides entering HeLa cell nuclei (PMID 22117547, title) | No |
| 2012 | Human embryonic bronchial cells in culture (PMID 22808515) | No — cells only |
| 2015 | Rat model of obstructive lung disease (PMID 26468022) | No |
| 2017 | Rat model of obstructive lung disease (PMID 30199201) | No |
| 2017 | Gene expression in tobacco plants (PMID 28371610, title) | No |
The lung studies are in rats. A team at the Pavlov First St Petersburg State Medical University's pulmonology institute exposed rats intermittently to nitrogen dioxide for 60 days to model chronic obstructive pulmonary disease. After a month of Bronchogen, they report the airway lining lost the features of the disease — goblet-cell hyperplasia, squamous metaplasia, lymphocyte infiltration, emphysema — and ciliated cells returned; secretory IgA rose and neutrophil inflammation fell (Kuzubova et al. 2015, PMID 26468022; Titova et al. 2017, PMID 30199201, which adds surfactant protein B). The abstracts do not give the dose or the number of rats.
In cell culture, Bronchogen raised the differentiation markers CXCL12 and Hoxa3 in human embryonic bronchial cells, more in late-passage "aging" cultures than in young ones (Khavinson et al. 2012, PMID 22808515). The same paper ran Pancragen (Lys-Glu-Asp-Trp) on pancreatic cells and Vesugen on prostate fibroblasts.
A detail the name search misses: searched by its sequence rather than its name, five of the 12 PubMed records for AEDL are about the roots of tobacco plants (2017–2026, e.g. PMID 39796141), where the peptide was tested as a growth signal.
What is not established
- Any effect in people. No record reports a lung outcome, symptom or measurement in a person, and ClinicalTrials.gov lists no study (2026-11-19).
- Dose and route in the rat studies, which the abstracts do not give.
- Independent replication outside St Petersburg. The two rat studies come from a separate St Petersburg institute; no group elsewhere has reported a lung study.
- Safety. No study reports giving it to anyone.
Where it stands
For a peptide named after the airways, the lung evidence amounts to two experiments in rats breathing nitrogen dioxide, and nothing in a person. Cough, breathlessness and diagnosed lung disease are matters for a respiratory clinician; this entry records the sequence, the papers and the gaps. Related entries: Cardiogen, Cortagen, Prostamax, Pinealon.
Sources opened 2026-11-19: PubChem (CID 11690869); PubMed E-utilities (searches; abstracts of PMIDs 21240358, 26468022, 30199201, 22808515, 36979488; titles of the others); ClinicalTrials.gov API v2.
